批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/03/04 |
ORIG-1(原始申请) |
Approval |
|
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:GABAPENTIN 剂型/给药途径:TABLET;ORAL 规格:600MG 治疗等效代码:AB1
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020882 |
001 |
NDA |
NEURONTIN |
GABAPENTIN |
TABLET;ORAL |
600MG |
Prescription |
Yes |
No |
AB1 |
1998/10/09
|
VIATRIS |
075694 |
001 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB1 |
2004/10/21
|
ACTAVIS ELIZABETH |
077662 |
001 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB1 |
2006/08/18
|
GLENMARK PHARMS LTD |
077525 |
001 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
600MG |
Discontinued |
No |
No |
AB1 |
2006/08/24
|
SUN PHARM INDS LTD |
077661 |
004 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB1 |
2006/09/13
|
RUBICON |
078926 |
001 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB1 |
2011/02/11
|
ZYDUS PHARMS USA INC |
200651 |
001 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB1 |
2011/10/06
|
AUROBINDO PHARMA LTD |
202764 |
001 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
600MG |
Discontinued |
No |
No |
AB1 |
2012/10/16
|
INVAGEN PHARMS |
203244 |
002 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB1 |
2013/07/12
|
STRIDES PHARMA |
206402 |
001 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB1 |
2015/12/23
|
ALKEM LABS LTD |
205101 |
001 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB1 |
2016/02/04
|
SCIEGEN PHARMS INC |
207057 |
001 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB1 |
2017/10/26
|
CSPC OUYI |
214957 |
001 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB1 |
2021/10/01
|
ASCENT PHARMS INC |
217116 |
001 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB1 |
2023/03/28
|
GRANULES |
217995 |
001 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB1 |
2023/07/19
|
RISING |
211313 |
001 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB1 |
2024/03/04
|
STRIDES PHARMA |
217965 |
001 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB1 |
2024/04/08
|
LAURUS |
209855 |
001 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB1 |
2024/05/29
|
IPCA LABS LTD |
活性成分:GABAPENTIN 剂型/给药途径:TABLET;ORAL 规格:800MG 治疗等效代码:AB1
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020882 |
002 |
NDA |
NEURONTIN |
GABAPENTIN |
TABLET;ORAL |
800MG |
Prescription |
Yes |
Yes |
AB1 |
1998/10/09
|
VIATRIS |
075694 |
002 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
800MG |
Prescription |
No |
No |
AB1 |
2004/10/21
|
ACTAVIS ELIZABETH |
077662 |
002 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
800MG |
Prescription |
No |
No |
AB1 |
2006/08/18
|
GLENMARK PHARMS LTD |
077525 |
002 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
800MG |
Discontinued |
No |
No |
AB1 |
2006/08/24
|
SUN PHARM INDS LTD |
077661 |
005 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
800MG |
Prescription |
No |
No |
AB1 |
2006/09/13
|
RUBICON |
078926 |
002 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
800MG |
Prescription |
No |
No |
AB1 |
2011/02/11
|
ZYDUS PHARMS USA INC |
200651 |
002 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
800MG |
Prescription |
No |
No |
AB1 |
2011/10/06
|
AUROBINDO PHARMA LTD |
202764 |
002 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
800MG |
Discontinued |
No |
No |
AB1 |
2012/10/16
|
INVAGEN PHARMS |
203244 |
001 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
800MG |
Prescription |
No |
No |
AB1 |
2013/07/12
|
STRIDES PHARMA |
206402 |
002 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
800MG |
Prescription |
No |
No |
AB1 |
2015/12/23
|
ALKEM LABS LTD |
205101 |
002 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
800MG |
Prescription |
No |
No |
AB1 |
2016/02/04
|
SCIEGEN PHARMS INC |
207057 |
002 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
800MG |
Prescription |
No |
No |
AB1 |
2017/10/26
|
CSPC OUYI |
214957 |
002 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
800MG |
Prescription |
No |
No |
AB1 |
2021/10/01
|
ASCENT PHARMS INC |
217116 |
002 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
800MG |
Prescription |
No |
No |
AB1 |
2023/03/28
|
GRANULES |
217995 |
002 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
800MG |
Prescription |
No |
No |
AB1 |
2023/07/19
|
RISING |
211313 |
002 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
800MG |
Prescription |
No |
No |
AB1 |
2024/03/04
|
STRIDES PHARMA |
217965 |
002 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
800MG |
Prescription |
No |
No |
AB1 |
2024/04/08
|
LAURUS |
209855 |
002 |
ANDA |
GABAPENTIN |
GABAPENTIN |
TABLET;ORAL |
800MG |
Prescription |
No |
No |
AB1 |
2024/05/29
|
IPCA LABS LTD |